RHUMBLINE ADVISERS

Position in HCM — HUTCHMED (China) Ltd

CIK 1115418 BOSTON, MA

Position in HCM

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$61,276

+$7,530 QoQ

Shares Held

4,096

+1.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#29

of 54 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. HCM ranks #43 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,229,009	$145,281,153
2	UTHR	UNITED THERAPEUTICS Corp	122,486	$72,631,748
3	NBIX	Neurocrine Biosciences Inc	303,820	$40,025,246
4	ELAN	Elanco Animal Health Inc	1,268,203	$30,348,097
5	VTRS	Viatris Inc	1,941,082	$26,224,017
6	ALKS	Alkermes plc.	449,531	$15,895,416
7	LNTH	Lantheus Holdings, Inc.	194,563	$14,757,603
8	HIMS	Hims & Hers Health, Inc.	643,856	$13,366,450

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$61,276	4,096	+1.6%	Shares	Sole	2026-05-12
2025-12-31	$53,746	4,032	+46.2%	Shares	Sole	2026-02-13
2025-09-30	$43,422	2,757	-8.9%	Shares	Sole	2025-11-06
2025-06-30	$45,571	3,028	-8.2%	Shares	Sole	2025-08-12
2025-03-31	$49,632	3,300	-57.7%	Shares	Sole	2025-05-29
2024-12-31	$112,383	7,799	+1.2%	Shares	Sole	2025-05-29
2024-09-30	$150,556	7,709	+2.1%	Shares	Sole	2024-11-12
2024-06-30	$129,307	7,553	+8.1%	Shares	Sole	2024-08-01
2024-03-31	$117,415	6,989	+1.1%	Shares	Sole	2024-05-09
2023-12-31	$125,140	6,910	-14.7%	Shares	Sole	2024-02-08
2023-09-30	$137,281	8,104	0.0%	Shares	Sole	2023-11-09
2023-06-30	$97,248	8,104	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.